A blog about chemistry, drug development, science, and technology
Pages (999999): [1] 2 3 » ... Last »
More mergers, this time in the contract services area. Seems Aptuit will acquire SSCI.
RedOrbit - Health - Aptuit to Acquire SSCI
I have done work in the past with SSCI and find them to be an excellent company to do business with. They specialize in polymorph issues and have an great background in solid state characterization. Aptuit has reported they will keep all ~100 employees of SSCI there in West Lafayette, IN. I truly hope this doesn’t change the culture and work ethic of SSCI. I am always hesitant though having been through several mergers and knowing the problems and confusion that can result . Invariably the larger companies culture inculcates the smaller company and in my opinion, this stifles the advantages that the smaller company usually brings to the market. These include responsive customer service, as well as being able to change and adapt to changing circumstances quickly.
Maybe my fears are unfounded, but if my experience is any indication, it may mark the end of another innovative and adaptive company which was a pleasure to work with.
Technorati Tags: pharma M&A, pharmaceutical deals, Aptuit, SSCI
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
Pages (999999): [1] 2 3 » ... Last »
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.050 seconds